ALKEM LABS LTD FDA Approval ANDA 215948

ANDA 215948

ALKEM LABS LTD

FDA Drug Application

Application #215948

Application Sponsors

ANDA 215948ALKEM LABS LTD

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

FDA Submissions

UNKNOWN; ORIG1TA2023-01-09UNKNOWN

Submissions Property Types

ORIG1Null31

CDER Filings

ALKEM LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215948
            [companyName] => ALKEM LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"MIRABEGRON","activeIngredients":"MIRABEGRON","strength":"25MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"MIRABEGRON","activeIngredients":"MIRABEGRON","strength":"50MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/09\/2023","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2023-01-09
        )

)

© 2023 FDA.report
This site is not affiliated with or endorsed by the FDA.